Ofloxacin Ratiopharm (Ofloxacin)

Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By blocking these targets, the drug prevents bacterial cell division, leading to a bactericidal effect against a broad range of Gram‑negative and some Gram‑positive organisms.

The dosage of Ofloxacin Ratiopharm is determined by the prescribing healthcare professional based on the type and severity of infection, patient age, renal function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Ofloxacin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under the guidance of a qualified healthcare provider.

To request Ofloxacin Ratiopharm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ofloxacin shares the fluoroquinolone mechanism with agents such as ciprofloxacin and levofloxacin. Compared with ciprofloxacin, Ofloxacin often offers a similar spectrum but may have different dosing schedules and tissue penetration profiles, making it a suitable alternative when specific susceptibility patterns or patient factors favor its use.

Store Ofloxacin Ratiopharm at ambient temperature below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat, and direct sunlight to maintain potency throughout the shelf life.

Ofloxacin Ratiopharm is taken orally with a full glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal discomfort. Patients should swallow the tablet whole and follow the prescriber’s dosing schedule.

Serious adverse events include tendon rupture (especially the Achilles tendon), QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, peripheral neuropathy, and hepatic dysfunction. Any of these symptoms require immediate medical attention.

Ofloxacin should be avoided in patients with a known hypersensitivity to fluoroquinolones, a history of tendon disorders related to quinolone use, uncontrolled cardiac arrhythmias, or those taking medications that significantly prolong the QT interval. Clinicians must assess individual risk before prescribing.